Latest Breaking News On - Institutional investors weigh in on rhythm pharmaceuticals - Page 3 : comparemela.com

Brokerages Set Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) PT at $45.43

Brokerages Set Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) PT at $45.43
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Jennifer kayden leeHunterc smithInstitutional investors weigh in on rhythm pharmaceuticalsRhythm pharmaceuticalsChina universal asset management coSg americas securitiesWells fargo companyNews ratings for rhythm pharmaceuticals dailyAnalyst recommendations for rhythm pharmaceuticalsNational bankGoldman sachs groupRhythm pharmaceuticals incNeedham companyRhythm pharmaceuticals stockMorgan stanleyGet free report

Rhythm Pharmaceuticals (NASDAQ:RYTM) Trading Up 5.1%

Rhythm Pharmaceuticals (NASDAQ:RYTM) Trading Up 5.1%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesJoseph shulmanJennifer kayden leeLife insurance coRhythm pharmaceuticals incChicago partners investment groupNeedham companyRhythm pharmaceuticalsRhythm pharmaceuticals tradingInstitutional investors weigh in on rhythm pharmaceuticalsWells fargo companyMorgan stanleyGoldman sachs groupRhythm pharmaceuticals company profileChina universal asset management coAllspring global investments holdings

Rhythm Pharmaceuticals (NASDAQ:RYTM) Trading 5.1% Higher

Rhythm Pharmaceuticals (NASDAQ:RYTM) Trading 5.1% Higher
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Recursos ltdaHunterc smithJennifer kayden leeWells fargo companyWhittier trust coInstitutional investors weigh in on rhythm pharmaceuticalsSecurities exchange commissionRhythm pharmaceuticalsRhythm pharmaceuticals incNeedham companyRhythm pharmaceuticals price performanceVanguard group incNews ratings for rhythm pharmaceuticals dailyChina universal asset management coGoldman sachs groupMorgan stanley

Rhythm Pharmaceuticals (NASDAQ:RYTM) Shares Gap Down to $47.20

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Free Report)’s stock price gapped down prior to trading on Monday . The stock had previously closed at $47.20, but opened at $45.74. Rhythm Pharmaceuticals shares last traded at $46.02, with a volume of 87,390 shares trading hands. Wall Street Analysts Forecast Growth A number of research firms have […]

United statesHunterc smithJennifer kayden leeRhythm pharmaceuticals tradingRhythm pharmaceuticals incGoldman sachs groupRhythm pharmaceuticals company profileAllspring global investments holdingsLife insurance coWells fargo companyRhythm pharmaceuticalsInsider activity at rhythm pharmaceuticalsInstitutional investors weigh in on rhythm pharmaceuticalsNews ratings for rhythm pharmaceuticals dailyChina universal asset management coSecurities exchange commission

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Receives $37.71 Average PT from Analysts

Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Free Report) have received an average rating of “Moderate Buy” from the seven analysts that are presently covering the firm, Marketbeat reports. One research analyst has rated the stock with a hold rating and six have issued a buy rating on the company. The average 12-month price […]

United statesHunterc smithLife insurance coMorgan stanleyChicago partners investment groupChina universal asset management coNews ratings for rhythm pharmaceuticals dailyGoldman sachs groupAllspring global investments holdingsAnalyst recommendations for rhythm pharmaceuticalsNeedham companySecurities exchange commissionWells fargo companyInstitutional investors weigh in on rhythm pharmaceuticalsRhythm pharmaceuticals price performanceRhythm pharmaceuticals